C8-Ceramide
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


C8-Ceramide
Description:
C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. C8-Ceramide has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections. C8-Ceramide induces slight activation of protein kinase (PKC) in vitro[1][2][3][4].Product Name Alternative:
N-Octanoyl-D-erythro-sphingosineUNSPSC:
12352211Hazard Statement:
H302, H315, H319, H332, H335Target:
Apoptosis; Autophagy; PKCType:
Reference compoundRelated Pathways:
Apoptosis; Autophagy; Epigenetics; TGF-beta/SmadApplications:
COVID-19-anti-virusField of Research:
Cancer; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/c8-ceramide.htmlPurity:
98.0Solubility:
DMSO : ≥ 100 mg/mLSmiles:
CCCCCCCC(N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC)=OMolecular Formula:
C26H51NO3Molecular Weight:
425.69Precautions:
H302, H315, H319, H332, H335References & Citations:
[1]Rebeca López-Marure , et al. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis. Biochem Biophys Res Commun. 2002 May 10;293 (3) :1028-36.|[2]Curtis J. Pritzl, et al. A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections. J Immunol. 2015 May 1; 194 (9) : 4339-4349.|[3]Yuli C. Chang, et al. Exogenous C8-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells. Int J Mol Sci. 2018 Oct; 19 (10) : 3010.|[4]H W Huang, et al. Ceramides modulate protein kinase C activity and perturb the structure of Phosphatidylcholine/Phosphatidylserine bilayers. Biophys J. 1999 Sep; 77 (3) : 1489-1497.|[5]Lan Weiss, et al. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Hum Mol Genet. 2021 Jan 7; ddaa248.Shipping Conditions:
Blue IceStorage Conditions:
-20°C (Powder, stored under nitrogen)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
PKCCAS Number:
74713-59-0
